Indivior Pharmaceuticals, Inc. (INDV) insider buying and selling

NASDAQ: INDV · Source: SEC Form 4 filings · Latest trade reported

In the last 90 days at Indivior Pharmaceuticals, Inc. (INDV), 1 insider made 1 open-market purchase worth $54K and there were no open-market sales, as reported on SEC Form 4. Over the last 12 months, 2 insiders bought $54K of the stock, led by Woodrow D Anderson (Chief Accounting Officer), who bought $54K on Aug 27, 2026; 2 insiders sold $2.8M, of which $2.8M was scheduled or tax-related.

Insider buys, 90 days
1
$54K · 1 insider
Insider sales, 90 days
0
$0 · 0 insiders
Insider buys, 12 months
2
$54K · 2 insiders
Insider sales, 12 months
3
$2.8M · 2 insiders

This is the public summary. Create a free account to see INDV’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock INDV

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

Open-market insider trades at Indivior Pharmaceuticals, Inc.
DateInsiderTypeSharesPriceValue
Woodrow D Anderson
Chief Accounting Officer
Open market purchase1,500$35.69$54K
Barbara Ryan
Director
Open market purchase8$31.09$249

Scheduled and tax-related sales

Sales made under a pre-arranged 10b5-1 plan or to cover tax on vesting shares. They are listed separately because they are not a fresh decision to sell.

Scheduled and tax-related insider sales at Indivior Pharmaceuticals, Inc.
DateInsiderTypeSharesPriceValue
Christian Heidbreder
Chief Scientific Officer
10b5-1 sale18,586$41.14$765K
Christian Heidbreder
Chief Scientific Officer
10b5-1 sale18,586$38.06$707K
Ryan Preblick
CFO
10b5-1 sale36,000$37.70$1.4M

What the INDV insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for Indivior Pharmaceuticals, Inc. and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with INDV Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about INDV insider trading

Who bought Indivior Pharmaceuticals, Inc. (INDV) stock recently?

Insiders who bought Indivior Pharmaceuticals, Inc. stock on the open market in the last 12 months: Woodrow D Anderson ($54K), Barbara Ryan ($249). The most recent purchase was reported on Aug 27, 2026.

Are insiders buying or selling INDV?

Over the last 12 months insiders were net buyers of INDV on discretionary trades: $54K bought against $0 sold (scheduled and tax-related sales excluded).

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see INDV in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.